NCT01780701View on ClinicalTrials.gov

Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

March 31, 2017

Conditions
Prostate Cancer
Interventions
PROCEDURE

Magnetic Resonance Spectroscopy Imaging with rectal probe

Trial Locations (2)

97207

Portland VA Medical Center, Portland

97239

Oregon Health & Science University Advanced Imaging Research Center, Portland

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

Portland VA Medical Center

FED

collaborator

Oregon Health and Science University

OTHER

lead

OHSU Knight Cancer Institute

OTHER

NCT01780701 - Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer | Biotech Hunter | Biotech Hunter